Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 8, Number 5—May 2002
Research

Excess Mortality Associated with Antimicrobial Drug-Resistant Salmonella Typhimurium

Morten Helms*, Pernille Vastrup*, Peter Gerner-Smidt*, and Kåre Mølbak*Comments to Author 
Author affiliations: *Statens Serum Institut, Copenhagen, Denmark;

Main Article

Table 2

Two-year relative death rate of patients infected with Salmonella Typhimurium, by antimicrobial susceptibility pattern. Registry linkage study including 2,047 patients and a random matched sample of 20,456 people from the Danish general population

Resistant Susceptiblea
Deaths/cases RRb (95% CIc) Deaths/cases RR (95% CI) p-valued
Resistant to >1 drug 31/1,094 2.4 (1.6–3.7) 28/953 2.3 (1.5-3.5) 0.86
Ampicillin 13/393 3.5 (1.7-7.2) 46/1,654 2.1 (1.5-3.0) 0.21
Chloramphenicol 16/347 5.1 (2.6-10.2) 43/1,700 1.9 (1.4-2.8) 0.01
Streptomycin 13/458 2.1 (1.1-4.1) 46/1,589 2.4 (1.7-3.4) 0.76
Sulfonamides 31/969 2.5 (1.6-3.9) 28/1,078 2.1 (1.4-3.3) 0.60
Tetracycline 15/513 2.2 (1.2-4.1) 44/1,534 2.4 (1.7-3.4) 0.85
Kanamycin 3/108 23/1,018 3.9 (2.2-6.7)
Quinolone 5/83 10.3(2.8-37.8) 54/1,964 2.1 (1.6-3.0) 0.02
R-type ACSSuT 12/283 4.8 (2.2-10.5) 47/1,764 2.1 (1.5-2.9) 0.06
R-type ACSSuTNx 5/40 13.1 (3.3-51.9) 7/243e 2.9 (1.1-7.9) 0.09

aSusceptible refers to strains susceptible to the given antimicrobial drugs or combination of antimicrobial drugs; first cell refers to pansusceptible strains.
bDeath rate relative to the general population, as estimated by conditional proportional hazards regression analysis, controlling for underlying illness; RR=rate ratio.
cCI=confidence interval.
dp-value for test of homogeneity, i.e., RR for resistant being the same as for susceptible strains.
eStrains with R-type ACSSuT, but quinolone sensitve.

Main Article

Page created: July 15, 2010
Page updated: July 15, 2010
Page reviewed: July 15, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external